The PyroGene recombinant Factor C assay (rFC) assay represents a reliable, sustainable alternative to LAL.
Factor C is the first component in the horseshoe crab clotting cascade activated by endotoxin. Recombinant Factor C (rFC) is activated by endotoxin binding, and the active enzyme then cleaves a synthetic substrate, resulting in the generation of a fluorogenic compound.
The reaction is run in a 96-well microplate and is measured at time zero and after a one-hour incubation in a fluorescent microplate reader using 380 nm excitation/440 nm emission wavelengths. The log net fluorescence is proportional to the log endotoxin concentration and is linear in the 0.01-10 EU/mL range.
Benefits include: endotoxin specific, recombinant technology eliminates false-positive glucan reactions; predictable, reliable lot-to-lot assay performance; sustainable resource - no animal utilisation; endpoint fluorescent assay, comparable to other quantitative LAL methods; and 510 (K) submissions have been approved by the FDA using PyroGene rFC Assay as a final release test.
Phone: 03 9550 0883
BioGX Xfree COVID-19 Direct RT-PCR test
The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...
Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems
Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...
PCR Biosystems NGSBIO Library Quant Kit for Illumina
The kit contains all the components necessary for sensitive quantification of DNA libraries prior...
Learn More
I am interested in Lonza PyroGene rFC assay .
Complete the form and a supplier representative will be in touch.
